scispace - formally typeset
Journal ArticleDOI

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

TLDR
Indacaterol and tiotropium provided clinically relevant improvements in lung function with comparable safety profiles and the present data offer evidence consistent with current guidelines.
About
This article is published in The Lancet Respiratory Medicine.The article was published on 2013-09-01. It has received 230 citations till now. The article focuses on the topics: Tiotropium bromide & Indacaterol.

read more

Citations
More filters
Journal ArticleDOI

What to use INSTEAD of inhaled corticosteroids in COPD

TL;DR: Concerns about the balance of the risks and benefits of ICS-based treatments has led to renewed interest in defining patients who could be managed as well with other therapies, including fluticasone-based corticosteroids.
Journal ArticleDOI

Drugs for chronic obstructive pulmonary disease.

TL;DR: The drug and non-drug interventions that have dramatically improved the quality of life for patients with COPD are revealed.
Journal ArticleDOI

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.

TL;DR: The results from this study show that TIO is a cost-effective treatment compared to GLY in moderate to very severe COPD, well below the existing implicit and explicit willingness-to-pay thresholds.
Journal ArticleDOI

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

TL;DR: For treatment of patients with COPD in the UK over a lifetime horizon, treatment with UMEC dominates treatment with TIO, providing both improved health outcomes and cost savings.
Journal ArticleDOI

Olodaterol + tiotropium bromide for the treatment of COPD.

TL;DR: The large TOviTO program of Phase III clinical trials that is involving more than 15,000 patients with different levels of COPD severity worldwide and includes several clinical studies is documenting the efficacy and safety of tiotropium/olodaterol FDC as maintenance therapy in patients with moderate to very severe COPD.
References
More filters
Journal ArticleDOI

Standardisation of spirometry

TL;DR: This research presents a novel and scalable approach called “Standardation of LUNG FUNCTION TESTing” that combines “situational awareness” and “machine learning” to solve the challenge of integrating nanofiltration into the energy system.
Journal ArticleDOI

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

TL;DR: The St. George's Respiratory Questionnaire is a valid measure of impaired health in diseases of chronic airflow limitation that is repeatable and sensitive andMultivariate analysis demonstrated that SGRQ scores summed a number of areas of disease activity.
Journal ArticleDOI

The St George's Respiratory Questionnaire.

TL;DR: The St George's Respiratory Questionnaire is a standardized self-completed questionnaire for measuring impaired health and perceived well-being in airways disease and the background and rationale for its development are discussed together with an analysis of its performance.
Journal ArticleDOI

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

TL;DR: It is suggested that the frequency of exacerbations contributes to long term decline in lung function of patients with moderate to severe COPD.
Related Papers (5)